Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
20.53 EUR | +1.63% | -1.49% | +22.81% |
05:01pm | US FDA approves Moderna's RSV vaccine, its second marketed product | RE |
30/05 | Goldman Sachs Starts GSK With Neutral Rating, $47 Price Target | MT |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
GSK PLC | Other Pharmaceuticals | +1.44% | -1.49% | +22.81% | +30.64% | -5.31% | 89.9B | - | - | - |
Technical Rankings Surperformance
- Stock Market
- Equities
- GSK Stock
- GS71 Stock
- Charts GSK plc
- Comparison Chart